BSV acquires women’s health brand Tidilan EP News Bureau Apr 6, 2022 Tidilan is currently available in tablet and injectable dosage forms
SEC asks Bharat Serums to revise phase I/II trial protocols for equine antiserum to treat COVID-19 Usha Sharma Dec 28, 2020 The SEC has recommended grant of permission to conduct the clinical trial provided the company submits the revised clinical trial…
GenNext at SIRO Clinpharm Viveka Roychowdhury Dec 7, 2020 SIRO, one of India’s earliest CROs, is set to scale new heights, as its next-gen leaders chart out fresh strategies to sustain its…
Equine polyclonal antibodies have shown higher potency in in-vitro studies of SARS-CoV-2 virus… Usha Sharma Nov 3, 2020 Bharat Serums and Vaccines has initiated a research project to co-develop an equine polyclonal antibody, along with NIV, against…
Cadila buys JV partner’s 50 per cent stake in Zydus BSV Pharma Usha Sharma Mar 27, 2015 Zydus BSV has now become 100 per cent subsidiary of Cadila Healthcare